BD Launches BD OcuSeal™ Liquid Ocular Bandage

Innovative New Protective Barrier for Ophthalmic Surgery.

BD Medical – Ophthalmic Systems, a unit of BD (Becton, Dickinson and Company), announced today the European launch of BD OcuSeal Liquid Ocular Bandage, a fully synthetic protective barrier designed to provide comfort for post-surgical, post-traumatic, and non-traumatic ocular conditions. This product has European CE Mark approval, and BD intends to initiate registration in other countries including the United States.

BD OcuSeal Liquid Ocular Bandage is designed to help reduce the need for sutures and reduce complications typically associated with surgical incisions, including infection and patient discomfort. It is intended for direct application on corneal, conjunctival, and scleral surfaces.

BD OcuSeal Liquid Ocular Bandage consists of a synthetic hydrogel that is applied directly to the ocular surface as a liquid, using a special brush applicator. The hydrogel is activated by mixing two separate components. This product is engineered to form a low-profile, smooth, soft and transparent protective barrier film on the ocular surface.

“With the addition of BD OcuSeal Liquid Ocular Bandage to the BD family of single-use ophthalmic products, BD continues to demonstrate its commitment to improving patient safety during ophthalmic surgery,” says Doug Lawrence, Vice President and General Manager, BD Medical – Ophthalmic Systems. BD has an exclusive license from Hyperbranch Medical Technology to market BD OcuSeal Liquid Ocular Bandage for use in ophthalmology.